tirzepatide/levocarnitine brand name FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price 22% body weight F.D.A. Approves New Obesity Drug
Pay in 4 interest-free payments of $7.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
























